Luye Pharma Group Ltd

02186

Company Profile

  • Business description

    Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company’s highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs, Central nervous system drugs and others. It derives maximum revenue from the sale of Oncology drugs.

  • Contact

    Hongqiao Road 1438
    22/F, Gubei International Fortune Center II
    Changning District
    Shanghai264003
    CHN

    T: +86 2162376350

    https://www.luye.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    5,115

Stocks News & Analysis

stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.
stocks

Major ASX listed miners overvalued

We’ve adjusted our fair values after updating our commodity price assumptions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,138.6019.70-0.22%
CAC 408,054.8457.18-0.70%
DAX 4024,708.78250.28-1.00%
Dow JONES (US)48,898.58460.75-0.93%
FTSE 10010,114.0281.33-0.80%
HKSE26,487.5176.39-0.29%
NASDAQ23,202.33313.06-1.33%
Nikkei 22552,991.10592.47-1.11%
NZX 50 Index13,573.936.36-0.05%
S&P 5006,867.5672.45-1.04%
S&P/ASX 2008,815.9020.70-0.23%
SSE Composite Index4,113.650.35-0.01%

Market Movers